IP Library Granted Patent US 7,976,726
Granted Patent B2
US 7,976,726 · App. 11/740,213 · Granted Jul 12, 2011

Prevention of quantum dot quenching on metal surfaces

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,976,726
App. No.
11/740,213
Granted
Jul 12, 2011
Kind
B2
Abstract

A formulation comprises quantum dots and a quenching-preventive agent in a carrier material. The quenching-preventive agent is a metal chelating agents, a corrosion inhibitor, or a combination thereof. The formulation can be applied to a metal substrate, without experiencing metal ion induced fluorescence quenching.

Claims (16)

1. A formulation comprising:

a plurality of quantum dots selected from CdSe/ZnS and CdSeTe/ZnS; and

a metal chelating agent including (ethylenedinitrilo)tetraacetic acid (EDTA); and

a carrier material comprising water:methanol (1:1), polyacrylate and polyurethane.

2. The formulation of claim 1 wherein the metal chelating agent is present in the formulation at about from 1 mM to about 50 mM.

3. The formulation of claim 1 wherein the metal chelating agent is present in the formulation at about from 5 mM to about 15 mM.

4. The formulation of claim 1 wherein the quantum dots are further conjugated to a biomolecule.

5. The formulation of claim 4 wherein the biomolecule is protein or peptide.

6. The formulation of claim 1 wherein the quantum dots are present in the formulation at about 1 nM-500 nM.

7. The formulation of claim 1 wherein the quantum dots are present in the formulation at about 1 nM-100 nM.

8. The formulation of claim 1 wherein the quantum dots are present in the formulation at about 20 nM-50 nM.

9. The formulation of claim 1 further comprising a corrosion inhibitor.

10. The formulation of claim 9 wherein the corrosion inhibitor is present in the formulation at about 1 mM-50 mM.

11. The formulation of claim 9 wherein the corrosion inhibitor is present in the formulation at about 5 mM-20 mM.

12. The formulation of claim 9 wherein the corrosion inhibitor is benzotriazole, dithiothiadiazole, 2-aminopyrimidine, 5,6-dimethylbenzimidazole, 2-amino-5-mercapto-1,3,4-thiadiazole, 2-mercaptopyrimidine, 2-mercaptobenzoxazole, 2-mercaptobenzothiazole, or 2-mercaptobenzimidazole.

13. The formulation of claim 1 further comprising benzotriazole.

Assignments (4)
RELEASE Recorded Jul 21, 2011
From: SILICON VALLEY BANK
To: CAMBRIOS TECHNOLOGIES CORPORATION
Reel/Frame 026632/0532 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2011
From: CAMBRIOS TECHNOLOGIES CORPORATION
To: SILURIA TECHNOLOGIES, INC.
Reel/Frame 025769/0488 →
SECURITY AGREEMENT Recorded Oct 3, 2008
From: CAMBRIOS TECHNOLOGIES CORPORATION
To: SILICON VALLEY BANK
Reel/Frame 021633/0172 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2007
From: WANG, CHENG-I; DAI, HAIXIA; HEIDECKER, MANFRED
To: CAMBRIOS TECHNOLOGIES CORPORATION
Reel/Frame 020047/0322 →